Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

News

Competition and covid weigh on Appen

Lewis Jackson  |  14 May 2021Text size  Decrease  Increase  |  
Email to Friend

Julie Vonwiller couldn’t get a job as a linguist. Instead, she started a speech and language recognition company from her kitchen. Three years later in 1999, her husband left a senior role at Telstra to join her.

The company they founded, Appen, listed on the ASX on 7 January 2015 at 52 cents. By August last year it was trading above $40, a Dogecoin-like explosion of 6261.9 per cent.

The story since has been less rosy. Appen (ASX: APX) was down to $25.51 as 2021 began. It hit $11.11 on Thursday, a low not seen since 2018. It’s been a 74 per cent decline for investors who bought at the peak in August.

The Australian tech firm provides data and services to train the machine learning and artificial intelligence used by global technology companies, auto manufacturers and government agencies. It counts Microsoft among its clients.

Concerns arose last year that Appen was not going to meet revenue expectations, despite covid increasing the number of things done online. By the second half of the year evidence emerged that Appen's customers were pulling back on spending, according to ST Wong, CIO of Prime Value Asset Management.

"This started with smaller customers and then migrated to larger clients as well,” he says.

“Because of that narrative we felt that Appen's revenues against the valuation, which was very high, were at risk.”

Investing Compass
Listen to Morningstar Australia's Investing Compass podcast
Take a deep dive into investing concepts, with practical explanations to help you invest confidently.
Investing Compass

“We sold in August last year. We had held it for a number of years but saw the profit downgrade come through,” he added later.

Appen, which is outside Morningstar coverage, missed revenue estimates for 2H 2020, reporting $212.1 million against the median estimate of $258.2 million, according to data from Pitchbook.

The pullback was partly driven by uncertainty among Appen’s US clients as covid cases rapidly accelerated there at the end of 2020.

The share price decline since last August has made some analysts bullish about the future. Buy recommendations now outweigh sells by 4:1, according to Pitchbook.

But for Wong, it will take some time to determine how an increasingly competitive landscape will affect the company’s future.

"On the sell-side there are a number of buys, given the share price has collapsed and its trading at a pretty decent valuation,” he says.

“But what the market is grappling with now is how more competition will affect margins.

“We won't know the answer to that for another four to five months, we need to see how the profits come out in the next two halves before the market will become more comfortable with Appen."

Prime Value held a position worth about $1.45 million in Appen last June according to Morningstar Direct. Another Aussie fund, Greencape Capital, held a $3.1 million position at the end of January 2021, they have also since sold.

Declines across WAAAX stocks

Appen isn’t the only technology stock to return to earth. The WAAAX, a group of high-flying Aussie tech stocks made up of WiseTech, Appen, Altium, Afterpay, and Xero, have all fallen this year.

WAAAX returns (YTD and Since 1 Jan 2020)

WAAAX returns

Source: Morningstar Premium

Morningstar equity analyst Gareth James recently upgraded the fair value estimate (FVE) for WiseTech (ASX: WTC) up 8 per cent to $9, thanks to higher-earning growth forecasts. The stock closed Thursday at $26.23, a 191 per cent premium on the FVE.

Afterpay (ASX: APT) is now trading in a range Morningstar considers fairly valued, after months of trading at a significant premium. It closed on Thursday at $84.50. The shift reflects the 88 per cent upgrade to its fair value (to $75) in late March. The share price has also declined 24 per cent in May.

Xero (ASX: XRO) closed Thursday $111.8, a 155 per cent premium on the fair value estimate of $46.

Altium (ASX: ALU) is not covered by Morningstar.

These tech stocks have fallen as bond yields have marched upwards on the expectation that the economic recovery will drive up inflation and interest rates sooner than expected.

Yields on US 10-year Treasury bonds rose from 0.917 per cent in January to a peak of 1.745 per cent at the end of March, a 90 per cent increase. It was a similar story for Australian 10-year government bonds.

Higher interest rates can affect the valuations of growth stocks reliant on discounted future cash flows.

Correlation isn't always causation, US 10-year bond yields vs. Appen (26 Aug 2020 to 10 May 2021)

US-10 year bond yield vs. Appen

Source: Yahoo Finance AU

High valuations ultimately come with high expectations for revenue growth. Whenever the latter looks shaky, so does the former, says Wong.

"WAAAX stocks were trading at very high multiples on the expectation of very strong growth.

“But when you pull away one leg of that thesis, with revenue growth starting to falter, a key support of the high valuation was pulled out."

is a reporter and data journalist with Morningstar. Tweet him @lewjackk or get in touch via email

© 2021 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This information is to be used for personal, non-commercial purposes only. No reproduction is permitted without the prior written consent of Morningstar. Any general advice or 'regulated financial advice' under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), or its Authorised Representatives, and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information, refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ). Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Morningstar’s full research reports are the source of any Morningstar Ratings and are available from Morningstar or your adviser. Past performance does not necessarily indicate a financial product's future performance. To obtain advice tailored to your situation, contact a licensed financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782. The article is current as at date of publication.

Email To Friend